1100185

Reproductive Technologies, Inc. — FEI 3003343209

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 16, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Berkeley, CA (United States)

Citations

IDCFRDescription
1222221 CFR 1271.47(a)Design of procedures to ensure compliance
1223921 CFR 1271.55(b)(2)Listing and interpretation of CD tests performed
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
1228221 CFR 1271.75(d)Donors with risks not determined ineligible